KDM1A and neoplasm: Upon shRNA-induced knockdown of KDM1A, a moderate but significant decrease in cell viability was detected in all tested primary tumor-derived CRC-SCs (n = 4) and HCT116 cells, with more than 20% inhibition of cell viability over a timeframe of 9 days (Fig. 2B, C).